RECENT NEWS

The NHS workforce is more diverse than at any other point in its history, according to an annual report into race equality across the health service.

The 2023 England Rare Diseases Action Plan, published by the Department of Health and Social Care (DHSC) on Rare Disease Day - 28 February, aims to make sure people receive faster diagnosis and specialist care for rare diseases.

The full programme of lectures taking place at this year’s IBMS Congress is now available on the event’s website.

Clarapath, a robotics company aimed at catalysing change in the way pathology laboratories process human and animal tissue, has announced the acquisition of digital pathology company Crosscope.

Canon Medical has extended its Enterprise Imaging (EI) suite of solutions to include pathology through its partnership with Tribun Health. This provides new capability for healthcare organisations to efficiently include pathology into their enterprise imaging plans as part of their precision informatics roadmaps.

ViroStat has just released a number of monoclonal antibodies to the canine coronavirus. These new antibodies are specific to the nucleocapsid of the virus and do not cross react with other canine viruses. These antibodies form pairs for the rapid detection of the virus by immunoassay.

CN Bio, a leading organ-on-a-chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), has announced the commercial launch of the PhysioMimix Single-organ Higher Throughput (HT) System.

Genomics England has completed installation of an enterprise imaging system that will help to support a world-pioneering initiative for cancer research. The programme is linking whole genome sequencing, pathology and radiology data, in what has been described as the world’s largest multimodal cancer research platform.

INTEGRA Biosciences’ pipetting platforms are being used to streamline the liquid handling steps involved in antimicrobial susceptibility testing (AST), contributing to the early detection of antimicrobial resistance (AMR) and helping to direct patients onto the appropriate care pathway as soon as possible.

Mologic, the US subsidiary of Global Access Diagnostics (GADx), has announced that its proprietary COVI-Go SARS-CoV-2 Ag Self-Test received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for over-the-counter home use.

Veterinary diagnostics firm Enalees has announced the opening of a new subsidiary in Germany and the appointment of Philip Hausen as general manager for the Germany-Austria-Switzerland (DACH) region.

The Medical Technologies Directorate at the Department of Health and Social Care (DHSC) is hosting a webinar on Monday 6 March at 11am to promote the recently published Medical Technology Strategy.

Linkam Scientific will present a new cryo-electron microscopy (cryo-EM) research paper at the Microscopy Conference 2023 (MC2023), Darmstadt, Germany: ‘New principle and robot for vitrification of cryo-EM samples with controllable sample thickness and real-time optical inspection’.

Nicolas Shiaelis and Dr Nicole Robb, Oxford University scientists and co-founders of health technology company Pictura Bio, have developed a world-first diagnostic test, powered by artificial intelligence, that can identify known respiratory viruses such as influenza and COVID-19 within five minutes from just one nasal or throat swab.

Health Education England has published a capability framework that will allow for the health and care workforce to build up skills in artificial intelligence and digital healthcare technologies.

Roquefort Therapeutics has signed an exclusive licence and royalty agreement, for the field of medical diagnostics only, with Randox Laboratories, in relation to its Midkine antibody portfolio.

Tens of thousands of patients across the country will benefit from quicker access to tests, with 19 new community diagnostic centres (CDCs) which will perform 1.1 million tests, checks and scans every year set to open later this year.

The laboratory world will meet in Hannover on 9 – 11 May at Labvolution, the European trade fair for laboratory technology and optimised laboratory workflows.

Beckman Coulter Diagnostics and MeMed have announced a strategic partnership to jointly develop and commercialise the proven MeMed BV test, a host immune response diagnostic that is able to distinguish between bacterial and viral infections.

VolitionRx’s Nu.Q vet cancer test is now available for pre-order to veterinarians at the point-of-care through Heska Corporation.